16th Annual UC Davis Primary Care Pharmacotherapy Conference is organized by UC Davis Health and will be held during Apr 13 -15, 2018 at Napa Valley Marriott, Napa, California, United States of America.
The target audience for this medical event is primary care providers, specialists, pharmacists, nurse practitioners, physician assistants and nurses. This CME conference has been approved for a maximum of 16.25 AMA PRA Category 1 Credits.
Conference Highlights :
• Opioid Stewardship and Addiction in an Epidemic of Prescription Drug Abuse.
• Updates in the Management of Heart Failure.
• Review of Hypertension Management in Difficult to Manage Patients.
• Overview of PrEP Therapy in Primary Care.
• Updates in the Management of Diabetes.
• Hands on Review of Diabetes Devices.
• Overview of Oral Chemotherapy Treatments Relevant to Primary Care.
• Mental Health in Primary Care.
Conference Objectives are :
• Discuss the diagnostic criteria for Opioid Use Disorder (OUD).
• List the therapeutic options for OUD available to the primary care physician/nurse practitioner.
• Recognize the importance of treating comorbid depression associated with medical illnesses for optimal outcomes.
• Utilize the newest therapeutic guidelines and pharmaceutical agents available to treat mood and anxiety disorders.
• Describe an approach to managing pain that helps patients achieve optimal relief management while minimizing the risk of tolerance and addiction.
• Review previous treatment and risk factor control in patients with established diabetes.
• Explain the recent changes in regulatory expectations around opioids with emphasis on the CDC guidelines.
• List the medications with the strongest evidence to treat essential hypertension according to the JNC-8 Guidelines.
• Identify patients appropriate for PrEP therapy.
• Review new and current insulin delivery devices (pumps and pens) and an update on insurance coverage for diabetes devices.
• Review glucose monitoring devices including continuous glucose monitors.